Early growth response-1 in cardiovascular pathobiology.

The immediate-early gene product and zinc finger transcription factor early growth response (Egr)-1 plays a key master regulatory role in multiple cardiovascular pathological processes. This article reviews the amazing recent evidence implicating Egr-1 in atherosclerosis, intimal thickening after acute vascular injury, ischemic pathology, angiogenesis, allograft rejection, and cardiac hypertrophy.

[1]  M. Fu,et al.  Egr-1 target genes in human endothelial cells identified by microarray analysis. , 2003, Gene.

[2]  Y. Zou,et al.  Early Growth Response-1 Promotes Atherogenesis: Mice Deficient in Early Growth Response-1 and Apolipoprotein E Display Decreased Atherosclerosis and Vascular Inflammation , 2004, Circulation research.

[3]  L. Adam,et al.  Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries. , 1997, Circulation research.

[4]  L. Cheng,et al.  Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[5]  L. Khachigian,et al.  Catalytic Antisense DNA Molecules Targeting Egr-1 Inhibit Neointima Formation following Permanent Ligation of Rat Common Carotid Arteries , 2002, Thrombosis and Haemostasis.

[6]  T. Kita,et al.  Lysophosphatidylcholine Induces Early Growth Response Factor-1 Expression and Activates the Core Promoter of PDGF-A Chain in Vascular Endothelial Cells , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[7]  L. Khachigian,et al.  Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent. , 1999, The American journal of pathology.

[8]  K. Isobe,et al.  Effects of histone acetylation on transcriptional regulation of manganese superoxide dismutase gene. , 2002, Biochemical and biophysical research communications.

[9]  M. Rosenfeld,et al.  Simvastatin inhibits expression of tissue factor in advanced atherosclerotic lesions of apolipoprotein E deficient mice independently of lipid lowering: potential role of simvastatin-mediated inhibition of Egr-1 expression and activation. , 2003, Atherosclerosis.

[10]  L. Khachigian,et al.  New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury , 1999, Nature Medicine.

[11]  P. Zipfel,et al.  The Early Growth Response Protein (EGR-1) Regulates Interleukin-2 Transcription by Synergistic Interaction with the Nuclear Factor of Activated T Cells* , 1998, The Journal of Biological Chemistry.

[12]  J. Milbrandt,et al.  A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. , 1987, Science.

[13]  H. Drexler,et al.  Stretch-inducible Expression of the Angiogenic Factor CCN1 in Vascular Smooth Muscle Cells Is Mediated by Egr-1* , 2004, Journal of Biological Chemistry.

[14]  H. Aburatani,et al.  Genome-Wide Gene Expression Analysis for Induced Ischemic Tolerance and Delayed Neuronal Death following Transient Global Ischemia in Rats , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  Amyj . Williams,et al.  Inducible PDGF A-chain transcription in smooth muscle cells is mediated by Egr-1 displacement of Sp1 and Sp3. , 1997, The American journal of physiology.

[16]  Nigel Mackman,et al.  Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress , 2000, Nature Medicine.

[17]  N. Perkins,et al.  Inhibition of the RelA(p65) NF-κB Subunit by Egr-1* , 2000, The Journal of Biological Chemistry.

[18]  S. Kaneko,et al.  Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas. , 2003, The American journal of pathology.

[19]  J. Chiu,et al.  Endothelial exposure to hypoxia induces Egr‐1 expression involving PKCα‐mediated Ras/Raf‐1/ERK1/2 pathway , 2001, Journal of cellular physiology.

[20]  A. Alfranca,et al.  Up-regulation of vascular endothelial growth factor receptor Flt-1 after endothelial denudation: role of transcription factor Egr-1. , 2000, Blood.

[21]  Chunxiang Zhang,et al.  Blockade of Nuclear Factor of Activated T Cells Activation Signaling Suppresses Balloon Injury-induced Neointima Formation in a Rat Carotid Artery Model* , 2005, Journal of Biological Chemistry.

[22]  K. Kent,et al.  Elevated Egr-1 in Human Atherosclerotic Cells Transcriptionally Represses the Transforming Growth Factor-β Type II Receptor* , 2000, The Journal of Biological Chemistry.

[23]  M. Cybulsky,et al.  High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. , 2000, The Journal of clinical investigation.

[24]  Levon M Khachigian,et al.  Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth , 2003, Nature Medicine.

[25]  L. Khachigian,et al.  c-Jun Regulates Vascular Smooth Muscle Cell Growth and Neointima Formation after Arterial Injury , 2002, The Journal of Biological Chemistry.

[26]  Amyj . Williams,et al.  Egr-1-Induced Endothelial Gene Expression: A Common Theme in Vascular Injury , 1996, Science.

[27]  D. Pinsky,et al.  Transcriptional Control of Cardiac Allograft Vasculopathy by Early Growth Response Gene-1 (Egr-1) , 2002, Circulation research.

[28]  L. Lau,et al.  Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[29]  L. Chalifour,et al.  Altered molecular response to adrenoreceptor-induced cardiac hypertrophy in Egr-1-deficient mice. , 2000, American journal of physiology. Heart and circulatory physiology.

[30]  Eileen D. Adamson,et al.  A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization , 1988, Cell.

[31]  Y. Sadovsky,et al.  p300 Regulates the Synergy of Steroidogenic Factor-1 and Early Growth Response-1 in Activating Luteinizing Hormone-β Subunit Gene* , 2004, Journal of Biological Chemistry.

[32]  N. Mackman,et al.  Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. , 2001, Blood.

[33]  E. Fleck,et al.  TNFalpha induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2. , 2001, Atherosclerosis.

[34]  H R Herschman,et al.  Cloning of tetradecanoyl phorbol ester-induced 'primary response' sequences and their expression in density-arrested Swiss 3T3 cells and a TPA non-proliferative variant. , 1987, Oncogene.

[35]  M. Andrassy,et al.  PKCbeta regulates ischemia/reperfusion injury in the lung. , 2004, The Journal of clinical investigation.

[36]  L. Khachigian,et al.  Angiotensin II (ATII)-inducible Platelet-derived Growth Factor A-chain Gene Expression Is p42/44 Extracellular Signal-regulated Kinase-1/2 and Egr-1-dependent and Mediated via the ATII Type 1 but Not Type 2 Receptor , 1999, The Journal of Biological Chemistry.

[37]  N. Perkins,et al.  Inhibition of the RelA(p65) NF-kappaB subunit by Egr-1. , 2000, The Journal of biological chemistry.

[38]  T. Collins,et al.  Egr-1 is activated in endothelial cells exposed to fluid shear stress and interacts with a novel shear-stress-response element in the PDGF A-chain promoter. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[39]  Y. Zou,et al.  Hypoxia-associated Induction of Early Growth Response-1 Gene Expression* , 1999, The Journal of Biological Chemistry.

[40]  W. Aird,et al.  The proximal serum response element in the Egr-1 promoter mediates response to thrombin in primary human endothelial cells. , 2002, Blood.

[41]  J. Rupp,et al.  Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  L. Khachigian,et al.  FGF-1-induced platelet-derived growth factor-A chain gene expression in endothelial cells involves transcriptional activation by early growth response factor-1. , 1997, Circulation research.

[43]  P. Zipfel,et al.  Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression. , 2003, Nucleic acids research.

[44]  Chen Yan,et al.  ERK1/2 Associates with the c-Met-binding Domain of Growth Factor Receptor-bound Protein 2 (Grb2)-associated Binder-1 (Gab1) , 2004, Journal of Biological Chemistry.

[45]  R. Burke,et al.  Immediate early gene induction after neonatal hypoxia-ischemia. , 1993, Brain research. Molecular brain research.

[46]  B. Binder,et al.  Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1. , 1999, Blood.

[47]  K. Sakamoto,et al.  5' upstream sequence and genomic structure of the human primary response gene, EGR-1/TIS8. , 1991, Oncogene.

[48]  Amyj . Williams,et al.  Interplay of Sp1 and Egr-1 in the Proximal Platelet-derived Growth Factor A-Chain Promoter in Cultured Vascular Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.

[49]  P. Lemaire,et al.  Two mouse genes encoding potential transcription factors with identical DNA-binding domains are activated by growth factors in cultured cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Yoshimura,et al.  Inhibition of STAT3 prevents neointima formation by inhibiting proliferation and promoting apoptosis of neointimal smooth muscle cells. , 2003, Human gene therapy.

[51]  L. Mulligan,et al.  Transcriptional repression of the RET proto-oncogene by a mitogen activated protein kinase-dependent signalling pathway. , 2002, Gene.

[52]  M. Frid,et al.  Egr-1 antisense oligonucleotides inhibit hypoxia-induced proliferation of pulmonary artery adventitial fibroblasts. , 2005, Journal of applied physiology.

[53]  V. Sukhatme,et al.  Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. , 1995, Progress in nucleic acid research and molecular biology.

[54]  N. Mackman,et al.  Chlamydia pneumoniae Induces Tissue Factor Expression in Mouse Macrophages via Activation of Egr-1 and the MEK-ERK1/2 Pathway , 2003, Circulation research.

[55]  K. Lorenz,et al.  The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy , 2004, Nature Medicine.

[56]  B. Wasylyk,et al.  Ets ternary complex transcription factors. , 2004, Gene.

[57]  S. Bryant,et al.  Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1. , 1997, The American journal of pathology.

[58]  L. Khachigian,et al.  Catalytic Oligodeoxynucleotides Define a Key Regulatory Role for Early Growth Response Factor-1 in the Porcine Model of Coronary In-Stent Restenosis , 2001, Circulation research.

[59]  J. Milbrandt,et al.  Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Levon M Khachigian,et al.  Locked nucleic acid modified DNA enzymes targeting early growth response-1 inhibit human vascular smooth muscle cell growth. , 2004, Nucleic acids research.

[61]  L. Khachigian,et al.  Acute Local Release of Fibroblast Growth Factor-2 but not Transforming Growth Factor-β1 following Coronary Stenting , 2001, Thrombosis and Haemostasis.

[62]  T. Yue,et al.  Antisense oligonucleotides to the p65 subunit of NF-kB inhibit human vascular smooth muscle cell adherence and proliferation and prevent neointima formation in rat carotid arteries. , 1995, Biochemical and biophysical research communications.

[63]  L. Khachigian,et al.  New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury , 1999, Nature Medicine.

[64]  A. Kurtz,et al.  In vivo carbon monoxide exposure and hypoxic hypoxia stimulate immediate early gene expression , 1997, Pflügers Archiv.

[65]  J. Milbrandt,et al.  NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli , 1996, Molecular and cellular biology.

[66]  H. Schunkert,et al.  Expression of immediate early genes after cardioplegic arrest and reperfusion. , 1997, The Annals of thoracic surgery.

[67]  M. Aoki,et al.  Inhibition of neointimal hyperplasia after balloon injury by cis-element ‘decoy’ of early growth response gene-1 in hypercholesterolemic rabbits , 2004, Gene Therapy.

[68]  J. Milbrandt,et al.  Luteinizing Hormone Deficiency and Female Infertility in Mice Lacking the Transcription Factor NGFI-A (Egr-1) , 1996, Science.

[69]  P. Ratcliffe,et al.  Regulation of angiogenesis by hypoxia: role of the HIF system , 2003, Nature Medicine.

[70]  M. Braddock,et al.  The transcriptional corepressor NAB2 blocks Egr-1-mediated growth factor activation and angiogenesis. , 2001, Biochemical and biophysical research communications.

[71]  M. Andrassy,et al.  PKCβ regulates ischemia/reperfusion injury in the lung , 2004 .

[72]  T. Collins,et al.  Extinguishing Egr‐1‐dependent inflammatory and thrombotic cascades following lung transplantation , 2001 .

[73]  J. Milbrandt,et al.  Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1. , 1998, The Journal of clinical investigation.

[74]  V. Sukhatme,et al.  Expression of two "immediate early" genes, Egr-1 and c-fos, in response to renal ischemia and during compensatory renal hypertrophy in mice. , 1990, The Journal of clinical investigation.

[75]  Youhua Liu,et al.  Suppression of HGF receptor gene expression by oxidative stress is mediated through the interplay between Sp1 and Egr-1. , 2003, American journal of physiology. Renal physiology.

[76]  J. Gaughan,et al.  Early Growth Responsive Gene (Egr)-1 Expression Correlates with Cardiac Allograft Rejection , 2004, Transplantation.

[77]  L. Khachigian,et al.  Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2. , 1999, The American journal of pathology.

[78]  S. Her,et al.  Phenylethanolamine N-methyltransferase gene expression: synergistic activation by Egr-1, AP-2 and the glucocorticoid receptor. , 1998, Brain research. Molecular brain research.

[79]  F. Gruber,et al.  NAB2, a Corepressor of EGR-1, Inhibits Vascular Endothelial Growth Factor-mediated Gene Induction and Angiogenic Responses of Endothelial Cells* , 2003, The Journal of Biological Chemistry.

[80]  W. Schaper,et al.  Expression of nuclear proto-oncogenes in isoproterenol-induced cardiac hypertrophy. , 1993, Journal of molecular and cellular cardiology.

[81]  A. Serra,et al.  Hypoxia causes down‐regulation of 11β‐hydroxysteroid dehydrogenase type 2 by induction of Egr‐1 , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[82]  C. Allegra,et al.  Physical interaction between p53 and primary response gene Egr-1. , 2001, International journal of oncology.

[83]  R. Levy,et al.  Transcription factor Egr-1 in calcific aortic valve disease. , 2004, Journal of Heart Valve Disease.

[84]  M. Hori,et al.  Introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial α-smooth muscle actin expression and fibrosis in unilateral ureteral obstruction (UUO) rats , 2002, Gene Therapy.

[85]  M. Reidy,et al.  Basic fibroblast growth factor: its role in the control of smooth muscle cell migration. , 1993, The American journal of pathology.

[86]  R. Nagai,et al.  Early growth-response factor 1 and basic transcriptional element-binding protein 2 expression in cardiac allografts. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[87]  J. Drazen,et al.  Egr-1 and Sp1 interact functionally with the 5-lipoxygenase promoter and its naturally occurring mutants. , 1998, American journal of respiratory cell and molecular biology.

[88]  M. Mayo,et al.  Involvement of Egr-1/RelA Synergy in Distinguishing T Cell Activation from Tumor Necrosis Factor-α–induced NF-κB1 Transcription , 1997, The Journal of experimental medicine.

[89]  H. Ikeda,et al.  Differential modulation of gene expression among rat tissues with warm ischemia. , 2004, Experimental and molecular pathology.